Loading organizations...
Key people at TruMed.
TruMed was founded in 2019 by Kelly Ladner (Co-Founder , CEO) and Karen Whitaker (Co-Founder).
TruMed Systems, Inc. develops automated vaccine storage and handling solutions, providing comprehensive inventory management for medical practices. Its technology ensures optimal vaccine efficacy through precise temperature control and streamlined processes, reducing errors and improving efficiency for healthcare providers. This addresses critical needs in point-of-care immunization.
The company was co-founded in 2012 by Bob Manning and Gene Baker, who identified a critical need within healthcare for more sophisticated vaccine management. Their insight addressed inefficiencies and risks of traditional vaccine storage and handling in ambulatory settings. Manning and Baker sought to revolutionize how physician offices manage vaccines, ensuring integrity and availability.
TruMed Systems primarily serves individual clinics and physician offices, providing them with reliable tools to manage their vaccine supply. The company's long-term vision is to enhance public health by ensuring the medical community has access to solutions protecting against preventable diseases. By optimizing vaccine storage and delivery, TruMed Systems aims for better patient outcomes and minimizes waste.
Key people at TruMed.
TruMed was founded in 2019 by Kelly Ladner (Co-Founder , CEO) and Karen Whitaker (Co-Founder).
TruMed has 1 tracked investment across 1 company. The latest tracked deal is $110.0M Series B in Sanegene Bio in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 9, 2025 | Sanegene Bio | $110.0M Series B | — | ELI Lilly And Company, Invus, K2 Venture Partners, Lake Bleu Capital, Legend Capital, Northern Light Venture Capital, Oriza Holdings, Qiming Venture Partners, Sino Biopharmaceutical, SymBiosis, Tencent Holdings, TF Capital, Vivo Capital |